Surviving the impact of HIV-related illness in the Zambian business sector

AIDS Patient Care and STDs

Volumn 17, Issue 7, 2003, Pages 353-363

  Guinness, Lorna ^a,b   Walker, Damian ^a,b   Ndubani, Phillimon ^a,c   Jama, John ^a,c   Kelly, Paul ^a,c,d  

^a London School of Hygiene and Tropical Medicine ^*

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c University of Zambia   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; COMMERCIAL PHENOMENA; COST OF ILLNESS; DIARRHEA; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; POSTHUMOUS CARE; QUESTIONNAIRE; REVIEW; SEXUALLY TRANSMITTED DISEASE; TUBERCULOSIS; ZAMBIA;

EID: 0042810704     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729103322231295     Document Type: Review

References (31)

1. UNAIDS. Report on the Global HIV/AIDS epidemic. Geneva: UNAIDS, 2002.
2. Nicoll A, Bennett D, Catchpole M, et al. Sexual Health and Care: HIV, AIDS and Sexually Transmitted Diseases Infections. Global Epidemiology, Impact and Prevention. London: Public Health Laboratory Services, 1996.
3. Dixon S, McDonald S, Roberts J. The impact of HIV and AIDS on Africa's economic development. BMJ 2002;324:232-234.
4. Kelly P, Feldman R, Ndubani P. High adult mortality in Lusaka. Lancet 1998;351:883.
5. Barnett A, Whiteside A. AIDS in the Twenty-First Century. Disease and Globalization. Basingstoke/New York: Palgrave Macmillan, 2002.
6. Barnett A, Whiteside A. Guidelines for Studies of the Social and Economic Impact of HIV/AIDS. Geneva: UNAIDS, 2002.
7. Stover J, Bollinger L. The Economic Impact of AIDS: The Policy Project: Futures Group International/Research Triangle Institute/Centre for Development and Population Activities, 1999.
8. Buve A, Foster S, Mbwili C, et al. Mortality among female nurses in the face of the AIDS epidemic: A pilot study in Zambia. AIDS 1994;8:396.
9. Halswimmer M. The Social and Economic Impact of HIV/AIDS on Nakambala Sugar Estate. Rome, Italy: Food and Agriculture Organization of the United Nations, 1994.
10. Guinness L, Alban A. African Development Forum Discussion Paper: The Economic Impact of AIDS in Africa: A review of the Literature. Geneva, Switzerland: UNAIDS Background, 2000.
11. Ministry of Health Zambia, Central Board of Health. HIV/AIDS in Zambia: Background Projections, Impacts and Interventions. Zambia: Ministry of Health, 1997.
12. Chin'gambo L. Zambia: The Impact of HIV/AIDS on Productive Labor Force. Geneva: International Labor Organization, 1993.
13. Baggaley R, Godfery-Faussett P, Msiska R, et al. Impact of HIV on Zambian businesses. BMJ 1994;309: 1549-1550.
14. Whiteside A, O'Grady M, Alban A. The economic impact of HIV. Infothek 2000;4-9.
15. Ndubani P. An Epidemiological Assessment of the Prevalence of Sickness and Injuries Among Workers in Zambia Industry: The Case of Nakambala Sugar Estate [master's thesis]. Lusaka: University of Zambia, 1998.
16. Elliot A, Halwindi B, Hayes RJ, et al. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Trans R Soc Trop Med Hyg 1995;89:78-82.
17. Kelly P, Baboo KS, Wolff M, Ngwenya B, Luo N, Farthing MJ. The prevalence and aetiology of persistent diarrhea in adults in urban Zambia. Acta Trop 1996; 61:183-190.
18. Simon B. Employers slow to grasp reality. Financial Times September 20, 1999.
19. Forgy L. The Economic Impact of AIDS in Zimbabwe. Kenya: Regional Economic Development Services Offices for East and Southern Africa, 1993.
20. Clancy P. The Economic Impact of AIDS at Firm Level in Tanzania. University of East Anglia, 1998.
21. Cohen D. Socio-Economic Causes and Consequences of the HIV Epidemic in Southern Africa: A Case Study of Namibia. UNDP, 1997.
22. Strategic Caring: Firms strategise about AIDS. Economist October 5, 2002 http://www.economist.com/displaystory.cfm?story_id-1373275
23. World Bank. World Development Report: Investing in Health. Washington, D.C.: World Bank, 1993.
24. Anglaret X, Chene G, Attia A, et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: A randomized trial. Cotrimo-CI Study Group. Lancet 1999;353:1463-1468.
25. Bell JC, Rose DN, Sacks HS. Cost effectiveness of tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa. AIDS 1999;13:1549-1556.
26. Guinness L. Cost Effectiveness Analysis of Cotrimoxazole Prophylaxis for People Living with HIV/AIDS in Cote D'Ivoire [abstract 10PT3-207] XII International Conference on AIDS/STD in Africa. 9-13 December 2001. Ouagadougou, Burkina Faso, 2001.
27. Creese A, Floyd K, Alban A, Guinness L. Cost effectiveness of HIV/AIDS interventions in Africa: A review of the evidence. Lancet 2002;359:1635-1642.
28. Digging Deep: Anglo American offers AIDS drugs to all its employees. Economist August 10, 2002. http://www.economist.com/display.cfm?story_id-1273700
29. Fighting Back. AIDS: Similar problems, different responses in Botswana, Mozambique and South Africa. Economist May 9, 2002. http://www.economist.com/displaystory.cfm?story_id-1120109
30. Elliott AM, Luo N, Tembo G, et al. Impact of HIV on tuberculosis in Zambia: A cross sectional study. BMJ 1990;301:412-415.
31. Weiss HA, Buve A, Robinson NJ, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 2001;15(Suppl 4):S97-108.